PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Friedmann Angeli, J.P.* ; Krysko, D.V.* ; Conrad, M.

Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion.

Nat. Rev. Cancer 19, 405-414 (2019)
Postprint DOI PMC
Open Access Green
Ferroptosis is a recently recognized cell death modality that is morphologically, biochemically and genetically distinct from other forms of cell death and that has emerged to play an important role in cancer biology. Recent discoveries have highlighted the metabolic plasticity of cancer cells and have provided intriguing insights into how metabolic rewiring is a critical event for the persistence, dedifferentiation and expansion of cancer cells. In some cases, this metabolic reprogramming has been linked to an acquired sensitivity to ferroptosis, thus opening up new opportunities to treat therapy-insensitive tumours. However, it is not yet clear what metabolic determinants are critical for therapeutic resistance and evasion of immune surveillance. Therefore, a better understanding of the processes that regulate ferroptosis sensitivity should ultimately aid in the discovery of novel therapeutic strategies to improve cancer treatment. In this Perspectives article, we provide an overview of the known mechanisms that regulate sensitivity to ferroptosis in cancer cells and how the modulation of metabolic pathways controlling ferroptosis might reshape the tumour niche, leading to an immunosuppressive microenvironment that promotes tumour growth and progression.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
51.848
10.011
260
310
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Hydroperoxide Glutathione-peroxidase; Cell-death; Apoptotic Cells; Arachidonate Metabolism; Inhibits Ferroptosis; Lipid-peroxidation; Targeted Therapy; Dendritic Cells; Breast-cancer; Redox State
Sprache englisch
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 1474-175X
e-ISSN 1474-1768
Zeitschrift Nature Reviews - Cancer
Quellenangaben Band: 19, Heft: 7, Seiten: 405-414 Artikelnummer: , Supplement: ,
Verlag Nature Publishing Group
Verlagsort Macmillan Building, 4 Crinan St, London N1 9xw, England
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Metabolism and Cell Death (MCD)
Institute of Developmental Genetics (IDG)
POF Topic(s) 30203 - Molecular Targets and Therapies
30204 - Cell Programming and Repair
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-506900-001
G-500500-001
DOI 10.1038/s41568-019-0149-1
WOS ID WOS:000472883000014
Scopus ID 85066039097
PubMed ID 31101865
Erfassungsdatum 2019-05-21
[➜Korrektur melden]